Skip to main content
Showing 61-70 of 151 results
An integrated analysis of one phase 2 and two phase 3 clinical trials published today in The Lancet found that the investigational medication, brexanolone injection 90 µg/kg/h (formerly SAGE-547 injection), demonstrated a reduction in depressive symptoms in women suffering from moderate and severe postpartum depression (PPD) compared to placebo by the end of the primary timepoint of 60-hours...
Mike Ford makes waves with Team Hope
Feinstein Institute for Medical Research Professor Renée Pekmezaris, PhD, has been approved to receive a $3.03 million research award from the Patient-Centered Outcomes Research Institute (PCORI) to study home telemonitoring for patients in the Hispanic community living with type 2 diabetes...
Mike Ford makes waves with Team Hope
Feinstein Institute for Medical Research Professor Valentin A. Pavlov, PhD, received a five-year, $1.65 million R01 grant from the National Institutes of Health (NIH) to examine the vagus nerve's role in the inflammation and metabolism associated with sepsis...
Jason Econome, a Stuyvesant High School science teacher and resident of Garden City, NY, spent the summer at The Feinstein Institute for Medical Research with a globally-renowned lupus scientist, Betty Diamond, MD...
Rai helped launch an age of innovation in Leukemia
Researchers at the Feinstein Institute for Medical Research and Northwell Health's Department of Radiation Medicine have identified methods to increase use of the cutting-edge cancer radiation therapy, hypofractionation, in breast cancer patients...
Yousef Al-Abed, PhD, leads the Feinstein Institute's Center for Molecular Innovation, where he and his team are investigating new uses for old drugs.
Lenox Hill Hospital and The Feinstein Institute for Medical Research have been chosen as study site to identify biomarkers for focal seizures in patients with treatment-resistant epilepsy...
Go to top